poulvac bursine-2
zoetis south africa (pty) ltd - infectious bursal disease - vaccine - 10^7.2 tcid50
aplenzin er- bupropion hydrobromide tablet, extended release
stat rx usa llc - bupropion hydrobromide (unii: e70g3g5863) (bupropion - unii:01zg3tpx31) - bupropion hydrobromide 348 mg - aplenzin™ (bupropion hydrobromide extended-release tablets) is indicated for the treatment of major depressive disorder. the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled trials of inpatients and in one 6-week controlled trial of outpatients whose diagnoses corresponded most closely to the major depression category of the apa diagnostic and statistical manual (dsm) [see clinical studies (14) ] . a major depressive episode (dsm-iv) implies the presence of 1) depressed mood or 2) loss of interest or pleasure; in addition, at least 5 of the following symptoms have been present during the same 2-week period and represent a change from previous functioning: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide atte
creon for children 5000 gastro-resistant granules
abbott healthcare products ltd - pancreas powder - granules gastro-resistant - 60.36mg milligram
femoston 2/20
abbott healthcare products ltd - estradiol hemihydrate dydrogesterone - tablets - 2 mg, 20 m %v/v
lipantil supra 145mg film-coated tablets
abbott healthcare products ltd - fenofibrate - coated tablets - 145 milligram
acuvert 9 tab
solvay ph. - prochlorperazine - tab - 5mg - 9
ampidil 100 cap
solvay ph. - ampicillin - cap - 250mg - 100